Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Tales of the Shire: A The Lord of The Rings Game Launches on March 25, 2025
-
“The Conversations” by Wiley Ushers in New Era of Dialogue and Innovation in Scholarly Publishing
-
Concerns Around Ethical Risks of Generative AI Remain High Amid Increased Adoption: 'Deloitte State of Ethics and Trust in Technology' Report
-
ZEMA Global Data Corporation to Acquire Morningstar Commodity Data
-
Halia Therapeutics Reveals Promising Preclinical Obesity Data: HT-6184 and Semaglutide Combination Enhances Weight Loss and Preserves Lean Muscle Mass
-
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
-
Bunge Limited Finance Corp. Announces Results of Early Participation in Exchange Offers and Consent Solicitations
-
Monarch E&S Insurance Services Partners with Obsidian for Enhanced Personal Umbrella Coverage
-
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310
-
Wasabi Technologies Powers Johnson Controls with Unmatched Cloud Storage for Mission Critical Video Management
-
Musely is the #1 fastest growing tele-dermatology company in the last 4 years in the US, based on Inc. 5000
-
CION Investment Corporation Announces the Issuance of Additional $100 Million Floating Rate Senior Unsecured Notes due 2027
-
Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
-
New Family of Voltage-Controlled Saw Oscillators with Ultra-Low Phase Noise Performance for Radar Applications
-
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
-
Vermont Smoke & Cure and WhistlePig Whiskey Unveil Cocktail-Inspired Meat Stick
-
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
-
Harris Personal Injury Lawyers, Inc. Secures Three Top Spots on TopVerdict.com's "Number 1 Settlements in California in 2023" List
-
Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
-
Bracco Diagnostics Inc. Introduces CitraClear™, a Refreshing Pre-Procedure Hydration Solution, to the Healthcare Community
-
Icon Energy Corp. Announces the Delivery of M/V Bravo and the Signing of a Term Loan Facility for up to $91.5 million
-
ODYSIGHT.AI RECEIVES REPEAT PURCHASE ORDER FROM NASA FOR ITS COMPREHENSIVE VISUALIZATION SOLUTION, TO SUPPORT ITS HIGH-SPEED AERONAUTICAL FLIGHT TESTING
-
Nano Dimension Acquisition of Desktop Metal Receives Support from Leading Proxy Advisory Firm - ISS
-
Xunlei Announces Appointment of Two New Directors
-
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
-
Golden Matrix Group Subsidiary Meridianbet Partners With Integrity Compliance 360 for Upcoming Brazilian Market Entry
-
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
-
The Oncology Institute Announces CFO Transition
-
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
-
ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
-
Avenacy to Share Company’s Year One Progress at CPHI Milan 2024
-
IRCODE Redefines Advertising with Exact Match Technology, Transforming Static Platforms into Performance-Driven Channels and Empowering Brands to Control Visual Search and Brand Integrity
-
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
-
Applied Digital Sets Fiscal First Quarter 2025 Earnings Conference Call for Wednesday, October 9, 2024 at 5:00 p.m. Eastern Time
-
Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor)
-
Spur Therapeutics to Participate in Chardan’s 8th Annual Genetic Medicines Conference
-
Kratos SRE Welcomes Congressman Gary Palmer to Facility in Birmingham
-
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
-
Epilepsy Foundation Introduces New Mission & Vision Statements at National Leadership Conference
-
4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
-
Schouw & Co. share buy-back programme, week 38 2024
-
Crypto Proprietary Trading Firm HyroTrader Experiences Rapid Growth
-
Stanly Ranch Residences, Auberge Resorts Collection Announces First Closings Of Vineyard Homes and Villas In Napa Valley
-
ProStar Announces that a Global Fortune 500 Energy Company Adopts PointMan to Improve Refinery Maintenance Operations
-
Sage Software Welcomes Gotomyerp, A New Authorized Sage 100, 300 and Intacct Partner in the U.S. and Canada
-
Novo Nordisk A/S - share repurchase programme
-
Three Protocol Introduces Fraud-Resistant eCommerce Solutions, Pioneering Crypto as the Future of Payment
-
Bybit Türkiye Listed as a Crypto Asset Service Provider by the CMB
-
Sagexion Announces Launch with First Two Games: Meme Party and Ludo Sax
-
The Global Panda Partners 2024 Scheduled to Take Place in Chengdu by End of November
